Home › Type 2 Diabetes
Pag-aaral pangklinika para sa Type 2 Diabetes na nagre-recruit sa U.S.
245 pag-aaral para sa Type 2 Diabetes ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL25 pag-aaral
- Atlanta, GA21 pag-aaral
- San Diego, CA21 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL20 pag-aaral
- Chicago, IL19 pag-aaral
- Arlington, VA19 pag-aaral
- Los Angeles, CA18 pag-aaral
- Dallas, TX18 pag-aaral
- Columbus, OH17 pag-aaral
- Las Vegas, NV17 pag-aaral
- New York City, NY17 pag-aaral
- Birmingham, AL16 pag-aaral
- Philadelphia, PA16 pag-aaral
- Jacksonville, FL15 pag-aaral
- Havelock, NC14 pag-aaral
- Austin, TX14 pag-aaral
- Aurora, CO13 pag-aaral
- Indianapolis, IN13 pag-aaral
- Washington, DC13 pag-aaral
- Tucson, AZ13 pag-aaral
- Baltimore, MD13 pag-aaral
- Omaha, NE12 pag-aaral
- Cincinnati, OH12 pag-aaral
- Kansas City, MO11 pag-aaral
- Hialeah, FL11 pag-aaral
- Deltona, FL11 pag-aaral
- Salt Lake City, UT11 pag-aaral
- Pittsburgh, PA11 pag-aaral
- Edison, NJ10 pag-aaral
- Little Rock, AR10 pag-aaral
- Wichita, KS10 pag-aaral
- Concord, CA10 pag-aaral
- Sacramento, CA10 pag-aaral
- Memphis, TN10 pag-aaral
- New Haven, CT10 pag-aaral
- Durham, NC10 pag-aaral
- Long Beach, CA10 pag-aaral
Ayos sa estado
- Alabama22 pag-aaral
- Arizona25 pag-aaral
- Arkansas11 pag-aaral
- California74 pag-aaral
- Colorado18 pag-aaral
- Connecticut16 pag-aaral
- District of Columbia9 pag-aaral
- Florida49 pag-aaral
- Georgia37 pag-aaral
- Hawaii8 pag-aaral
- Idaho14 pag-aaral
- Illinois32 pag-aaral
- Indiana18 pag-aaral
- Iowa11 pag-aaral
- Kansas16 pag-aaral
- Kentucky12 pag-aaral
- Louisiana18 pag-aaral
- Maryland28 pag-aaral
- Massachusetts28 pag-aaral
- Michigan25 pag-aaral
- Minnesota18 pag-aaral
- Mississippi8 pag-aaral
- Missouri21 pag-aaral
- Montana4 pag-aaral
- Nebraska15 pag-aaral
- Nevada17 pag-aaral
- New Jersey15 pag-aaral
- New Mexico11 pag-aaral
- New York34 pag-aaral
- North Carolina37 pag-aaral
- North Dakota6 pag-aaral
- Ohio39 pag-aaral
- Oklahoma13 pag-aaral
- Oregon7 pag-aaral
- Pennsylvania33 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina19 pag-aaral
- South Dakota3 pag-aaral
- Tennessee20 pag-aaral
- Texas59 pag-aaral
- Utah19 pag-aaral
- Virginia29 pag-aaral
- Washington23 pag-aaral
- West Virginia9 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Nagre-recruit
Edad 2 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07864168A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07748208A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07024823Food Insecurity Reduction & Strategy Team
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06329375Gut Microbiota in Metabolic Surgery
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05000996Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Nob 9, 2026 · NCT07293715Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryoMay bayad para sa mga kalahok
Edad 14 hanggang 16 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06943001Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
Nagre-recruit
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07065721A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07351058A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07668336Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05472441Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07843485A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07881458A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07282600Clinical Decision Support for SGLT2i After AKI in Type 2 Diabetes
Nagre-recruit
Edad 30 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07868666A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07915609A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07783802Culturally Tailored Program for Food-Insecure Adults: SPICE-D
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07361341Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.